LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Managing the "Three Cs" of Academic Literature Authorship: Contributions, Credit, and Conflict.

    Thurston, Maria Miller / Moniri, Nader H / Phillip Bowen, J / Lea Winkles, C / Miller, Susan W

    American journal of pharmaceutical education

    2023  Volume 87, Issue 5, Page(s) 100009

    Abstract: Dissemination of information through publications is central to academic research, as well as professional advancement. Although seemingly a straightforward endeavor, publication authorship may present challenges. Although the International Committee of ... ...

    Abstract Dissemination of information through publications is central to academic research, as well as professional advancement. Although seemingly a straightforward endeavor, publication authorship may present challenges. Although the International Committee of Medical Journal Editors defines authorship based on 4 required criteria, contemporary interdisciplinary collaborations can complicate authorship determinations. However, communication that occurs early and frequently in the research and writing process can help to prevent or mitigate potential conflicts, while a process for defining authorship contributions can aid in awarding proper credit. The Contributor Roles Taxonomy (CRediT) defines 14 essential roles of manuscript authors that can be utilized to characterize individual author contributions toward any given publication. This information is useful for academic administrators when evaluating contributors of faculty during promotion and tenure decisions. In the era of collaborative scientific, clinical, and pedagogical scholarship, providing faculty development, including statements of credit in the published work, and developing institutional systems to capture and assess contributions are key.
    MeSH term(s) Humans ; Authorship ; Publishing ; Education, Pharmacy ; Writing ; Communication
    Language English
    Publishing date 2023-03-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603807-4
    ISSN 1553-6467 ; 0002-9459
    ISSN (online) 1553-6467
    ISSN 0002-9459
    DOI 10.1016/j.ajpe.2022.10.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation.

    Zhang, Changwen / Sajith, Ayyiliath M / Xu, Xiaotian / Jiang, Jianxiong / Phillip Bowen, J / Kulkarni, Amol / Hao, Jiukuan

    Bioorganic & medicinal chemistry

    2022  Volume 58, Page(s) 116645

    Abstract: The nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome plays an important role in microglia-mediated inflammation. Dysregulation of NLRP3 signaling results in microglial activation and triggers inflammatory ... ...

    Abstract The nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome plays an important role in microglia-mediated inflammation. Dysregulation of NLRP3 signaling results in microglial activation and triggers inflammatory responses contributing to the development of neurological disorders including ischemic stroke, schizophrenia, Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Inhibition of the NLRP3-linked inflammatory pathways reduces microglia-induced inflammation and is considered as a promising therapeutic approach for neuro-inflammatory diseases. In the present study, we report the development of AMS-17, a rationally-designed tertiary sulfonylurea compound for inhibition of inflammation in microglia. AMS-17 inhibited expression of the NLRP3, and its downstream components and cytokines such as caspase-1, tumor necrosis factor-α (TNF-α), IL-1β and inducible nitric oxide synthase (iNOS). It also suppressed lipopolysaccharide (LPS)-induced N9 microglial cell phagocytosis in vitro and activation of the microglia in mouse brain in vivo. Together, these results provide promising evidences for the inhibitory effects of AMS-17 in inflammation. This proof-of-concept study provides a new chemical scaffold, designed with the aid of pharmacophore modeling, with NLRP3 inhibitory activity which can be further developed for the treatment of inflammation-associated neurological disorders.
    MeSH term(s) Animals ; Cells, Cultured ; Dose-Response Relationship, Drug ; Inflammation/drug therapy ; Inflammation/metabolism ; Mice ; Microglia/drug effects ; Microglia/metabolism ; Models, Molecular ; Molecular Structure ; NLR Family, Pyrin Domain-Containing 3 Protein/antagonists & inhibitors ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Signal Transduction/drug effects ; Structure-Activity Relationship ; Sulfonylurea Compounds/chemical synthesis ; Sulfonylurea Compounds/chemistry ; Sulfonylurea Compounds/pharmacology
    Chemical Substances NLR Family, Pyrin Domain-Containing 3 Protein ; Nlrp3 protein, mouse ; Sulfonylurea Compounds
    Language English
    Publishing date 2022-01-31
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2022.116645
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top